<http://purl.org/healthcarevocab/v1#Tag.0078.0010> <http://www.w3.org/2002/07/owl#equivalentProperty> <http://purl.org/healthcarevocab/v1#ImplantTemplateGroupDescription> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#Tag.0078.0010> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#Tag.0078.0010> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/healthcarevocab/v1> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#Tag.0078.0010> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#Tag.0078.0010> <http://www.w3.org/2000/01/rdf-schema#label> "Implant Template Group Description" <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#Tag.0078.0010> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/healthcarevocab/v1#IE.ImplantTemplateGroup> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#Tag.300A.0072> <http://www.w3.org/2002/07/owl#equivalentProperty> <http://purl.org/healthcarevocab/v1#FractionGroupDescription> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#Tag.300A.0072> <http://www.w3.org/2000/01/rdf-schema#label> "Fraction Group Description" <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#Tag.300A.0072> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#Tag.300A.0072> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/healthcarevocab/v1> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#Tag.300A.0072> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/healthcarevocab/v1#SequenceItem.FractionGroupSequence> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#Tag.300A.0072> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#Tag.0070.0208> <http://www.w3.org/2002/07/owl#equivalentProperty> <http://purl.org/healthcarevocab/v1#GraphicGroupDescription> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#Tag.0070.0208> <http://www.w3.org/2000/01/rdf-schema#label> "Graphic Group Description" <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#Tag.0070.0208> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#Tag.0070.0208> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/healthcarevocab/v1> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#Tag.0070.0208> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/healthcarevocab/v1#SequenceItem.GraphicGroupSequence> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#Tag.0070.0208> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#GraphicGroupDescription> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#GraphicGroupDescription> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#GraphicGroupDescription> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/healthcarevocab/v1> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#GraphicGroupDescription> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/healthcarevocab/v1#SequenceItem.GraphicGroupSequence> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#GraphicGroupDescription> <http://www.w3.org/2002/07/owl#equivalentProperty> <http://purl.org/healthcarevocab/v1#Tag.0070.0208> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#GraphicGroupDescription> <http://www.w3.org/2000/01/rdf-schema#label> "Graphic Group Description" <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#DisplaySetPresentationGroupDescription> <http://www.w3.org/2002/07/owl#equivalentProperty> <http://purl.org/healthcarevocab/v1#Tag.0072.0206> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#DisplaySetPresentationGroupDescription> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#DisplaySetPresentationGroupDescription> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/healthcarevocab/v1> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#DisplaySetPresentationGroupDescription> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/healthcarevocab/v1#SequenceItem.DisplaySetsSequence> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#DisplaySetPresentationGroupDescription> <http://www.w3.org/2000/01/rdf-schema#label> "Display Set Presentation Group Description" <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#DisplaySetPresentationGroupDescription> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#FractionGroupDescription> <http://www.w3.org/2002/07/owl#equivalentProperty> <http://purl.org/healthcarevocab/v1#Tag.300A.0072> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#FractionGroupDescription> <http://www.w3.org/2000/01/rdf-schema#label> "Fraction Group Description" <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#FractionGroupDescription> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#FractionGroupDescription> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/healthcarevocab/v1> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#FractionGroupDescription> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/healthcarevocab/v1#SequenceItem.FractionGroupSequence> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#FractionGroupDescription> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#Tag.0072.0206> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#Tag.0072.0206> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#Tag.0072.0206> <http://www.w3.org/2000/01/rdf-schema#label> "Display Set Presentation Group Description" <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#Tag.0072.0206> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/healthcarevocab/v1> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#Tag.0072.0206> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/healthcarevocab/v1#SequenceItem.DisplaySetsSequence> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#Tag.0072.0206> <http://www.w3.org/2002/07/owl#equivalentProperty> <http://purl.org/healthcarevocab/v1#DisplaySetPresentationGroupDescription> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#ImplantTemplateGroupDescription> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#DatatypeProperty> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#ImplantTemplateGroupDescription> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/healthcarevocab/v1> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#ImplantTemplateGroupDescription> <http://www.w3.org/2002/07/owl#equivalentProperty> <http://purl.org/healthcarevocab/v1#Tag.0078.0010> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#ImplantTemplateGroupDescription> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2000/01/rdf-schema#Literal> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#ImplantTemplateGroupDescription> <http://www.w3.org/2000/01/rdf-schema#label> "Implant Template Group Description" <http://purl.org/healthcarevocab/v1> .
<http://purl.org/healthcarevocab/v1#ImplantTemplateGroupDescription> <http://www.w3.org/2000/01/rdf-schema#domain> <http://purl.org/healthcarevocab/v1#IE.ImplantTemplateGroup> <http://purl.org/healthcarevocab/v1> .
<http://purl.org/ontology/mo/Membership> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://purl.org/ontology/mo/> <http://purl.org/ontology/mo/> .
<http://purl.org/ontology/mo/Membership> <http://www.w3.org/2000/01/rdf-schema#comment> "A membership event, where one or several people belongs to a group during a particular time period." <http://purl.org/ontology/mo/> .
<http://purl.org/ontology/mo/Membership> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.org/ontology/mo/> .
<http://purl.org/ontology/mo/Membership> <http://www.w3.org/2003/06/sw-vocab-status/ns#term_status> "testing" <http://purl.org/ontology/mo/> .
<http://purl.org/ontology/mo/Membership> <http://www.w3.org/2000/01/rdf-schema#label> "membership" <http://purl.org/ontology/mo/> .
<http://purl.org/ontology/mo/Membership> <http://purl.org/ontology/mo/level> "1" <http://purl.org/ontology/mo/> .
<http://purl.org/ontology/mo/Membership> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.org/NET/c4dm/event.owl#Event> <http://purl.org/ontology/mo/> .
<http://www.biopax.org/release/biopax-level3.owl#EntityReference> <http://www.w3.org/2002/07/owl#disjointWith> <http://www.biopax.org/release/biopax-level3.owl#BioSource> <http://www.biopax.org/release/biopax-level3.owl> .
<http://www.biopax.org/release/biopax-level3.owl#EntityReference> <http://www.w3.org/2002/07/owl#disjointWith> <http://www.biopax.org/release/biopax-level3.owl#ExperimentalForm> <http://www.biopax.org/release/biopax-level3.owl> .
<http://www.biopax.org/release/biopax-level3.owl#EntityReference> <http://www.w3.org/2002/07/owl#disjointWith> <http://www.biopax.org/release/biopax-level3.owl#Score> <http://www.biopax.org/release/biopax-level3.owl> .
<http://www.biopax.org/release/biopax-level3.owl#EntityReference> <http://www.w3.org/2002/07/owl#disjointWith> <http://www.biopax.org/release/biopax-level3.owl#EntityFeature> <http://www.biopax.org/release/biopax-level3.owl> .
<http://www.biopax.org/release/biopax-level3.owl#EntityReference> <http://www.w3.org/2002/07/owl#disjointWith> <http://www.biopax.org/release/biopax-level3.owl#ControlledVocabulary> <http://www.biopax.org/release/biopax-level3.owl> .
<http://www.biopax.org/release/biopax-level3.owl#EntityReference> <http://www.w3.org/2002/07/owl#disjointWith> <http://www.biopax.org/release/biopax-level3.owl#KPrime> <http://www.biopax.org/release/biopax-level3.owl> .
<http://www.biopax.org/release/biopax-level3.owl#EntityReference> <http://www.w3.org/2002/07/owl#disjointWith> <http://www.biopax.org/release/biopax-level3.owl#SmallMolecule> <http://www.biopax.org/release/biopax-level3.owl> .
<http://www.biopax.org/release/biopax-level3.owl#EntityReference> <http://www.w3.org/2002/07/owl#disjointWith> <http://www.biopax.org/release/biopax-level3.owl#Stoichiometry> <http://www.biopax.org/release/biopax-level3.owl> .
<http://www.biopax.org/release/biopax-level3.owl#EntityReference> <http://www.w3.org/2002/07/owl#disjointWith> <http://www.biopax.org/release/biopax-level3.owl#ChemicalStructure> <http://www.biopax.org/release/biopax-level3.owl> .
<http://www.biopax.org/release/biopax-level3.owl#EntityReference> <http://www.w3.org/2002/07/owl#disjointWith> <http://www.biopax.org/release/biopax-level3.owl#DeltaG> <http://www.biopax.org/release/biopax-level3.owl> .
<http://www.biopax.org/release/biopax-level3.owl#EntityReference> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://www.biopax.org/release/biopax-level3.owl> .
<http://www.biopax.org/release/biopax-level3.owl#EntityReference> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://www.biopax.org/release/biopax-level3.owl#UtilityClass> <http://www.biopax.org/release/biopax-level3.owl> .
<http://www.biopax.org/release/biopax-level3.owl#EntityReference> <http://www.w3.org/2002/07/owl#disjointWith> <http://www.biopax.org/release/biopax-level3.owl#Xref> <http://www.biopax.org/release/biopax-level3.owl> .
<http://www.biopax.org/release/biopax-level3.owl#EntityReference> <http://www.w3.org/2002/07/owl#disjointWith> <http://www.biopax.org/release/biopax-level3.owl#SequenceLocation> <http://www.biopax.org/release/biopax-level3.owl> .
<http://www.biopax.org/release/biopax-level3.owl#EntityReference> <http://www.w3.org/2002/07/owl#disjointWith> <http://www.biopax.org/release/biopax-level3.owl#Provenance> <http://www.biopax.org/release/biopax-level3.owl> .
<http://www.biopax.org/release/biopax-level3.owl#EntityReference> <http://www.w3.org/2002/07/owl#disjointWith> <http://www.biopax.org/release/biopax-level3.owl#Evidence> <http://www.biopax.org/release/biopax-level3.owl> .
<http://www.biopax.org/release/biopax-level3.owl#EntityReference> <http://www.w3.org/2000/01/rdf-schema#comment> "Definition: An entity reference is a grouping of several physical entities across different contexts and molecular states, that share common physical properties and often named and treated as a single entity with multiple states by biologists. \n\nRationale:   Many protein, small molecule and gene databases share this point of view, and such a grouping is an important prerequisite for interoperability with those databases. Biologists would often group different pools of molecules in different contexts under the same name. For example cytoplasmic and extracellular calcium have different effects on the cell's behavior, but they are still called calcium. For DNA, RNA and Proteins the grouping is defined based on a wildtype sequence, for small molecules it is defined by the chemical structure.\n\nUsage: Entity references store the information common to a set of molecules in various states described in the BioPAX document, including database cross-references. For instance, the P53 protein can be phosphorylated in multiple different ways. Each separate P53 protein (pool) in a phosphorylation state would be represented as a different protein (child of physicalEntity) and all things common to all P53 proteins, including all possible phosphorylation sites, the sequence common to all of them and common references to protein databases containing more information about P53 would be stored in a Entity Reference.  \n\nComments: This grouping has three semantic implications:\n\n1.  Members of different pools share many physical and biochemical properties. This includes their chemical structure, sequence, organism and set of molecules they react with. They will also share a lot of secondary information such as their names, functional groupings, annotation terms and database identifiers.\n\n2. A small number of transitions seperates these pools. In other words it is relatively easy and frequent for a molecule to transform from one physical entity to another that belong to the same reference entity. For example an extracellular calcium can become cytoplasmic, and p53 can become phosphorylated. However no calcium virtually becomes sodium, or no p53 becomes mdm2. In the former it is the sheer energy barrier of a nuclear reaction, in the latter sheer statistical improbability of synthesizing the same sequence without a template. If one thinks about the biochemical network as molecules transforming into each other, and remove edges that respond to transcription, translation, degradation and covalent modification of small molecules, each remaining component is a reference entity.\n\n3. Some of the pools in the same group can overlap. p53-p@ser15 can overlap with p53-p@thr18. Most of the experiments in molecular biology will only check for one state variable, rarely multiple, and never for the all possible combinations. So almost all statements that refer to the state of the molecule talk about a pool that can overlap with other pools. However no overlaps is possible between molecules of different groups." <http://www.biopax.org/release/biopax-level3.owl> .
<http://www.biopax.org/release/biopax-level3.owl#EntityReference> <http://www.w3.org/2002/07/owl#disjointWith> <http://www.biopax.org/release/biopax-level3.owl#PhysicalEntity> <http://www.biopax.org/release/biopax-level3.owl> .
<http://www.biopax.org/release/biopax-level3.owl#EntityReference> <http://www.w3.org/2002/07/owl#disjointWith> <http://www.biopax.org/release/biopax-level3.owl#PathwayStep> <http://www.biopax.org/release/biopax-level3.owl> .
<http://www.cidoc-crm.org/cidoc-crm/E66_Formation> <http://www.w3.org/2000/01/rdf-schema#label> "Событие Формирования"@ru <http://www.cidoc-crm.org/cidoc-crm/> .
<http://www.cidoc-crm.org/cidoc-crm/E66_Formation> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://www.cidoc-crm.org/cidoc-crm/E7_Activity> <http://www.cidoc-crm.org/cidoc-crm/> .
<http://www.cidoc-crm.org/cidoc-crm/E66_Formation> <http://www.w3.org/2000/01/rdf-schema#label> "Formação"@pt <http://www.cidoc-crm.org/cidoc-crm/> .
<http://www.cidoc-crm.org/cidoc-crm/E66_Formation> <http://www.w3.org/2000/01/rdf-schema#label> "Gruppenbildung"@de <http://www.cidoc-crm.org/cidoc-crm/> .
<http://www.cidoc-crm.org/cidoc-crm/E66_Formation> <http://www.w3.org/2000/01/rdf-schema#comment> "This class comprises events that result in the formation of a formal or informal E74 Group of people, such as a club, society, association, corporation or nation. \nE66 Formation does not include the arbitrary aggregation of people who do not act as a collective.\nThe formation of an instance of E74 Group does not mean that the group is populated with members at the time of formation. In order to express the joining of members at the time of formation, the respective activity should be simultaneously an instance of both E66 Formation and E85 Joining. \n"@en <http://www.cidoc-crm.org/cidoc-crm/> .
<http://www.cidoc-crm.org/cidoc-crm/E66_Formation> <http://www.w3.org/2000/01/rdf-schema#label> "Formation"@en <http://www.cidoc-crm.org/cidoc-crm/> .
<http://www.cidoc-crm.org/cidoc-crm/E66_Formation> <http://www.w3.org/2000/01/rdf-schema#label> "Formation"@fr <http://www.cidoc-crm.org/cidoc-crm/> .
<http://www.cidoc-crm.org/cidoc-crm/E66_Formation> <http://www.w3.org/2000/01/rdf-schema#label> "Συγκρότηση Ομάδας"@el <http://www.cidoc-crm.org/cidoc-crm/> .
<http://www.cidoc-crm.org/cidoc-crm/E66_Formation> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://www.cidoc-crm.org/cidoc-crm/E63_Beginning_of_Existence> <http://www.cidoc-crm.org/cidoc-crm/> .
<http://www.cidoc-crm.org/cidoc-crm/E66_Formation> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2000/01/rdf-schema#Class> <http://www.cidoc-crm.org/cidoc-crm/> .
<http://www.ebu.ch/metadata/ontologies/ebucore/ebucore#groupDescription> <http://www.w3.org/2000/01/rdf-schema#domain> <http://www.ebu.ch/metadata/ontologies/ebucore/ebucore#Group> <http://www.ebu.ch/metadata/ontologies/ebucore/ebucore> .
<http://www.ebu.ch/metadata/ontologies/ebucore/ebucore#groupDescription> <http://www.w3.org/2000/01/rdf-schema#range> <http://www.w3.org/2001/XMLSchema#string> <http://www.ebu.ch/metadata/ontologies/ebucore/ebucore> .
<http://www.ebu.ch/metadata/ontologies/ebucore/ebucore#groupDescription> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> <http://www.ebu.ch/metadata/ontologies/ebucore/ebucore> .
<http://www.ebu.ch/metadata/ontologies/ebucore/ebucore#groupDescription> <http://www.w3.org/2000/01/rdf-schema#label> "Group description"@en <http://www.ebu.ch/metadata/ontologies/ebucore/ebucore> .
<http://www.ebu.ch/metadata/ontologies/ebucore/ebucore#groupDescription> <http://www.w3.org/2000/01/rdf-schema#comment> "A textual description of a\n            Group."@en <http://www.ebu.ch/metadata/ontologies/ebucore/ebucore> .
<http://erlangen-crm.org/current/E66_Formation> <http://www.w3.org/2000/01/rdf-schema#comment> "Scope note: \nThis class comprises events that result in the formation of a formal or informal E74 Group of people,\nsuch as a club, society, association, corporation or nation.\n\nE66 Formation does not include the arbitrary aggregation of people who do not act as a collective.\nThe formation of an instance of E74 Group does not require that the group is populated with members\nat the time of formation. In order to express the joining of members at the time of formation, the\nrespective activity should be simultaneously an instance of both E66 Formation and E85 Joining.\n\nExamples:\n the formation of the CIDOC CRM Special Interest Group\n the formation of the Soviet Union\n the conspiring of the murderers of Caesar\n\nIn First Order Logic:\nE66(x) ⊃ E7(x)\nE66(x) ⊃ E63(x)"@en <http://erlangen-crm.org/current/> .
<http://erlangen-crm.org/current/E66_Formation> <http://www.w3.org/2000/01/rdf-schema#subClassOf> _:B0e20a249222d9dba8b21b6415dba9584 <http://erlangen-crm.org/current/> .
<http://erlangen-crm.org/current/E66_Formation> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://erlangen-crm.org/current/E7_Activity> <http://erlangen-crm.org/current/> .
<http://erlangen-crm.org/current/E66_Formation> <http://www.w3.org/2000/01/rdf-schema#label> "E66 Formation"@en <http://erlangen-crm.org/current/> .
<http://erlangen-crm.org/current/E66_Formation> <http://www.w3.org/2004/02/skos/core#notation> "E66" <http://erlangen-crm.org/current/> .
<http://erlangen-crm.org/current/E66_Formation> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://erlangen-crm.org/current/E63_Beginning_of_Existence> <http://erlangen-crm.org/current/> .
<http://erlangen-crm.org/current/E66_Formation> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://erlangen-crm.org/current/> .
<http://purl.obolibrary.org/obo/OBI_0500006> <http://www.w3.org/2000/01/rdf-schema#label> "parallel group design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500006> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500006> <http://purl.obolibrary.org/obo/IAO_0000112> "PMID: 17408389-Purpose: Proliferative vitreoretinopathy (PVR) is the most important reason for blindness following retinal detachment. Presently, vitreous tamponades such as gas or silicone oil cannot contact the lower part of the retina. A heavier-than-water tamponade displaces the inflammatory and PVR-stimulating environment from the inferior area of the retina. The Heavy Silicone Oil versus Standard Silicone Oil Study (HSO Study) is designed to answer the question of whether a heavier-than-water tamponade improves the prognosis of eyes with PVR of the lower retina. Methods: The HSO Study is a multicentre, randomized, prospective controlled clinical trial comparing two endotamponades within a two-arm parallel group design. Patients with inferiorly and posteriorly located PVR are randomized to either heavy silicone oil or standard silicone oil as a tamponading agent. Three hundred and fifty consecutive patients are recruited per group. After intraoperative re-attachment, patients are randomized to either standard silicone oil (1000 cSt or 5000 cSt) or Densiron((R)) as a tamponading agent. The main endpoint criteria are complete retinal attachment at 12 months and change of visual acuity (VA) 12 months postoperatively compared with the preoperative VA. Secondary endpoints include complete retinal attachment before endotamponade removal, quality of life analysis and the number of retina affecting re-operation within 1 year of follow-up. Results: The design and early recruitment phase of the study are described. Conclusions: The results of this study will uncover whether or not heavy silicone oil improves the prognosis of eyes with PVR."@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500006> <http://purl.obolibrary.org/obo/IAO_0000114> <http://purl.obolibrary.org/obo/IAO_0000125> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500006> <http://purl.obolibrary.org/obo/IAO_0000119> "http://www.holah.karoo.net/experimentaldesigns.htm"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500006> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://purl.obolibrary.org/obo/OBI_0500000> <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500006> <http://purl.obolibrary.org/obo/IAO_0000117> "Philippe Rocca-Serra"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500006> <http://purl.obolibrary.org/obo/IAO_0000115> "A parallel group design or independent measure design is a study design which uses unique experimental unit each experimental group, in other word no two individuals are shared between experimental groups, hence also known as parallel group design. Subjects of a treatment group receive a unique combination of independent variable values making up a treatment"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500006> <http://purl.obolibrary.org/obo/IAO_0000118> "independent measure design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://purl.obolibrary.org/obo/OBI_0500006> <http://purl.obolibrary.org/obo/IAO_0000111> "parallel group design"@en <http://purl.obolibrary.org/obo/obi.owl> .
<http://www.w3.org/ns/csvw#groupChar> <http://www.w3.org/2000/01/rdf-schema#label> "group character"@en <http://www.w3.org/ns/csvw#> .
<http://www.w3.org/ns/csvw#groupChar> <http://www.w3.org/2000/01/rdf-schema#range> _:B6d0fa003f1bdfab1b34801bfc544d6a8 <http://www.w3.org/ns/csvw#> .
<http://www.w3.org/ns/csvw#groupChar> <http://www.w3.org/2000/01/rdf-schema#comment> "A string whose value is used to group digits within the number."@en <http://www.w3.org/ns/csvw#> .
<http://www.w3.org/ns/csvw#groupChar> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> <http://www.w3.org/ns/csvw#> .
<http://www.w3.org/ns/csvw#groupChar> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <http://www.w3.org/ns/csvw#> <http://www.w3.org/ns/csvw#> .
<http://www.w3.org/ns/csvw#groupChar> <http://www.w3.org/2000/01/rdf-schema#domain> <http://www.w3.org/ns/csvw#NumericFormat> <http://www.w3.org/ns/csvw#> .
<http://vocab.datex.org/terms#dimensionOfGroup> <http://www.w3.org/2000/01/rdf-schema#comment> "Dimension of a virtual rectangle encapsulating the group of parking spaces. Use 'dimensionUsableArea' to define the total space available for parking within this group. Do not use 'dimensionHeight'."@en <http://vocab.datex.org/terms#> .
<http://vocab.datex.org/terms#dimensionOfGroup> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> <http://vocab.datex.org/terms#> .
<http://purl.org/cwmo/#Subject> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <http://purl.org/cwmo/#> .
<http://purl.org/cwmo/#Subject> <http://www.w3.org/2000/01/rdf-schema#comment> "The subject class is the description of the problerm to solve by the creative group during the creative workshop. It is a transformation/reformulation of the problem."@en <http://purl.org/cwmo/#> .
<http://purl.org/cwmo/#Subject> <http://www.w3.org/2000/01/rdf-schema#label> "Subject"@en <http://purl.org/cwmo/#> .
<https://bmake.th-brandenburg.de/spv#ResMethActionResearch> <https://schema.org/url> "http://doi.org/10.1007/s11576-007-0064-z" <https://bmake.th-brandenburg.de/spv> .
<https://bmake.th-brandenburg.de/spv#ResMethActionResearch> <http://www.w3.org/2003/06/sw-vocab-status/ns#term_status> "stable" <https://bmake.th-brandenburg.de/spv> .
<https://bmake.th-brandenburg.de/spv#ResMethActionResearch> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#NamedIndividual> <https://bmake.th-brandenburg.de/spv> .
<https://bmake.th-brandenburg.de/spv#ResMethActionResearch> <http://www.w3.org/2000/01/rdf-schema#isDefinedBy> <https://bmake.th-brandenburg.de/spv#> <https://bmake.th-brandenburg.de/spv> .
<https://bmake.th-brandenburg.de/spv#ResMethActionResearch> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <https://bmake.th-brandenburg.de/spv#ResearchMethod> <https://bmake.th-brandenburg.de/spv> .
<https://bmake.th-brandenburg.de/spv#ResMethActionResearch> <http://www.w3.org/2000/01/rdf-schema#comment> "Solving a practice problem by a mixed group of scientists and practical experts. Several cycles of analysis, action and evaluation steps, each with a low level of structured instruments such as group discussions or planning games, are conducted."@en <https://bmake.th-brandenburg.de/spv> .
<https://bmake.th-brandenburg.de/spv#ResMethActionResearch> <http://www.w3.org/2000/01/rdf-schema#label> "Action Research (Wilde/Hess)"@en <https://bmake.th-brandenburg.de/spv> .
<http://theme-e.adaptcentre.ie/dave#hasValueMetric> <http://www.w3.org/2000/01/rdf-schema#label> "has Value Metric"@en <http://theme-e.adaptcentre.ie/dave/dave.ttl> .
<http://theme-e.adaptcentre.ie/dave#hasValueMetric> <http://www.w3.org/2000/01/rdf-schema#comment> "This property will link a data metric group (dave:MetricGroup) to the related metrics (dave:Metric)."@en <http://theme-e.adaptcentre.ie/dave/dave.ttl> .
<http://theme-e.adaptcentre.ie/dave#hasValueMetric> <http://www.w3.org/2000/01/rdf-schema#range> <http://theme-e.adaptcentre.ie/dave#Metric> <http://theme-e.adaptcentre.ie/dave/dave.ttl> .
<http://theme-e.adaptcentre.ie/dave#hasValueMetric> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#ObjectProperty> <http://theme-e.adaptcentre.ie/dave/dave.ttl> .
<http://theme-e.adaptcentre.ie/dave#hasValueMetric> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/1999/02/22-rdf-syntax-ns#Property> <http://theme-e.adaptcentre.ie/dave/dave.ttl> .
<http://theme-e.adaptcentre.ie/dave#hasValueMetric> <http://www.w3.org/2000/01/rdf-schema#domain> <http://theme-e.adaptcentre.ie/dave#MetricGroup> <http://theme-e.adaptcentre.ie/dave/dave.ttl> .
<https://w3id.org/idsa/core/ServiceIsolationGuarantee> <http://www.w3.org/2002/07/owl#equivalentClass> _:B4965cfaa9f695fde23761a5d14089e2c <https://w3id.org/idsa/core> .
<https://w3id.org/idsa/core/ServiceIsolationGuarantee> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <https://w3id.org/idsa/core/SecurityGuarantee> <https://w3id.org/idsa/core> .
<https://w3id.org/idsa/core/ServiceIsolationGuarantee> <http://www.w3.org/2000/01/rdf-schema#comment> "Service isolation mechanism supported by the Connector. Examples are process group (Docker) or by least privilege with clear separation and support for additional security modules as done by trustme."@en <https://w3id.org/idsa/core> .
<https://w3id.org/idsa/core/ServiceIsolationGuarantee> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> <https://w3id.org/idsa/core> .
<https://w3id.org/idsa/core/ServiceIsolationGuarantee> <http://www.w3.org/2000/01/rdf-schema#label> "Service isolation"@en <https://w3id.org/idsa/core> .
